Dissection of the Active Ingredients and Potential Mechanism of Han-Shi-Yu-Fei-Decoction in Treating COVID-19 Based on In Vivo Substances Profiling and Clinical Symptom-Guided Network Pharmacology-Reference-Cited by-同舟云学术

Dissection of the Active Ingredients and Potential Mechanism of Han-Shi-Yu-Fei-Decoction in Treating COVID-19 Based on In Vivo Substances Profiling and Clinical Symptom-Guided Network Pharmacology

Published:2022-10-07 Issue:41 Volume:7 Page:36598-36610
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Jiao Guangyang¹^ORCID,Fan Xiangcheng²³^ORCID,Wang Yejian⁴,Weng Nan²⁵,Ouyang Luolan⁶,Wang Haoqian⁶,Pan Sihan⁶,Huang Doudou¹,Han Jun⁷,Zhang Feng²³⁴,Chen Wansheng¹²³^ORCID

Affiliation:

1. Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

2. Department of Pharmacy, Changzheng Hospital, (Second Military Medical University), Naval Medical University, Shanghai 200003, China

3. Shanghai Key Laboratory for Pharmaceutical Metabolite Research, Shanghai 200433, China

4. Department of Pharmacology, Anhui University of Chinese Medicine, Hefei 230012, Anhui, China

5. School of Traditional Chinese Material, Shenyang Pharmaceutical University, Shenyang 11001, China

6. School of Pharmacy, Shanghai University of Chinese Medicine, Shanghai 201203, China

7. Department of Gastroenterology, Changzheng Hospital, (Second Military Medical University), Naval Medical University, Shanghai 200003, China

Funder

National Natural Science Foundation of China

Shanghai Changzheng Hospital

Jin-Zi-Ta Talent projects

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c04589

Reference52 articles.

1. After the pandemic: perspectives on the future trajectory of COVID-19

2. Traditional Chinese medicine in COVID-19

3. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

4. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism analysis of essential oil from Radix Bupleuri for the treatment of asthma through regulation of ectopic olfactory receptor;Journal of Ethnopharmacology;2024-11

2. Disease Evolution-based Specificity Target Discovery (DESTD) by analyzing Jiawei-Maxing-Shigan Decoctions against COVID-19;European Journal of Integrative Medicine;2024-09

3. Using HS-GC-MS and flash GC e-nose in combination with chemometric analysis and machine learning algorithms to identify the varieties, geographical origins and production modes of Atractylodes lancea;Industrial Crops and Products;2024-03

4. Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation;Journal of Food and Drug Analysis;2023-08-31

5. Near-infrared spectroscopy combined with machine learning for rapid identification of Atractylodis rhizoma decoction pieces;Industrial Crops and Products;2023-07